The 'New' New Way To Sell Prescription Medications
•InnovationThe 'New' New Way To Sell Prescription MedicationsByAdam Wolfberg,Forbes Councils Member.for Forbes Technology CouncilCOUNCIL POSTExpertise from Forbes Councils members, operated under licen...
•Opinions expressed are those of the author.
•| Membership (fee-based)Jun 08, 2026, 07:45am EDTAdam Wolfberg, MD, is chief medical officer at Virta Health, where he leads a clinical team focused on treatment of diabetes and obesity.
هذا الخبر من Forbes. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
InnovationThe 'New' New Way To Sell Prescription MedicationsByAdam Wolfberg,Forbes Councils Member.for Forbes Technology CouncilCOUNCIL POSTExpertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. | Membership (fee-based)Jun 08, 2026, 07:45am EDTAdam Wolfberg, MD, is chief medical officer at Virta Health, where he leads a clinical team focused on treatment of diabetes and obesity. gettyThe fastest, least-expensive way to find a doctor who will prescribe Zepbound for weight loss may be to visit the drug company's website.It didn't used to be that way. For decades, pharmaceutical companies weren't allowed to market to patients in the U.S. When the industry convinced regulators to allow patient-focused advertising, the floodgates opened. In 2023, pharmaceutical companies spent nearly $14 billion on consumer advertising. Still, patients had to talk to their doctor to receive a prescription, and their doctor could always talk them out of a bad idea.Now, Lilly can send you to an online physician who will prescribe your Zepbound, and Lilly's in-house pharmacy will ship the weight loss drug to your door. Don't actually "need" Zepbound? Well, that's between you and the doctor Lilly referred you to.This is possible because of a vertically integrated software stack sitting behind the LillyDirect interface: structured intake forms, asynchronous prescribing and employer payment rails that bypass traditional insurance infrastructure. Lilly has built a direct-to-consumer fulfillment system that operates more like a software company than a pharmaceutical one.(Although my employer, Virta Health, focuses on nutrition-first management of metabolic disease, our clinicians do prescribe Zepbound and Wegovy to clinically appropriate patients. We do not receive referrals from drug manufacturers.)The shift isn't only about convenience. Besides developing a relationship directly wit...المصدر: Forbes | Source: Forbes
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Forbes. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Forbes. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.


